Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2008
12/31/2008CN101332245A Decoction for treating influenza
12/31/2008CN101332239A Externally used drug for treating tinea
12/31/2008CN101332235A Magnolia bark and processing technique
12/31/2008CN101332216A Xingsiang Tuerfeng total phenolic acid extract and preparation method thereof
12/31/2008CN101332202A Tobramycin lotion and preparation method thereof
12/31/2008CN101332196A Amoxicillin/clavulanate potassium dispersible tablets and preparation method thereof
12/31/2008CN101332188A Method for preparing powder injection using superfine communication technique and prepared products
12/31/2008CN101332187A Aminophenylsulfone liposome and preparation method thereof
12/31/2008CN101332185A SiRNA liposome preparation
12/31/2008CN101331911A New use of clove leaves for preventing and treating yellow and white scour of piglets
12/31/2008CN100447247C Recombinant infectious non-segmented negative strand RNA virus
12/31/2008CN100447154C Use of HMG fragments as anti-inflammatory agents
12/31/2008CN100447136C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors
12/31/2008CN100446814C Compound econazole nitrate film forming gel composition and its use
12/31/2008CN100446813C Hepatitis A-hepatitis E combined vaccine and preparation method thereof
12/31/2008CN100446812C MVA expressing modified HIV envelope, GAG, and pol genes
12/31/2008CN100446811C Composition comprising immunogenic microparticles
12/31/2008CN100446803C Chinese herbal medicine decoction for treating scrofula and preparing method
12/31/2008CN100446797C Dripping pills of 'Da Yuan Yin' and preparation method thereof
12/31/2008CN100446793C Chinese-medicinal composition for treating enterogastric diseases
12/31/2008CN100446783C Method for preparing injection of astragalus
12/31/2008CN100446774C Clindamycin hydrochloride vaginal effervescent tablet and its preparing method
12/31/2008CN100446754C Prepn process of skin icing snake fat ointment
12/31/2008CN100446753C Clotrimazole gel, and its prepn. method
12/31/2008CA2692221A1 Treatment of urinary tract infections with a mixture of saponin and an antibiotic
12/31/2008CA2692200A1 Low-additive influenza vaccines
12/31/2008CA2692182A1 Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors
12/31/2008CA2690710A1 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
12/31/2008CA2690708A1 Vaccine
12/31/2008CA2690707A1 Vaccine
12/31/2008CA2689330A1 Combination formulations
12/31/2008CA2685533A1 Vaccine against clostridium perfringens
12/30/2008US7470704 Benzonaphthyridines
12/30/2008US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance
12/30/2008US7470687 Aryl oximes
12/30/2008US7470686 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
12/30/2008US7470681 Pyrimidine compounds
12/30/2008US7470666 injecting an aqueous solution containing dissolved freeze-dried ulinastatin powder; glycoprotein isolated from human urine, and also called human urine trypsin enzyme inhibitor
12/30/2008US7470506 Fitness assay and associated methods
12/30/2008US7470430 Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization
12/30/2008US7470428 Compositions and methods useful for promoting or reducing T-cell trafficking to a target tissue. Also provided are compositions and methods useful for promoting or inhibiting antigen-presenting cell (APC) activation. The invention is
12/30/2008CA2400237C Pluraflavins and derivatives thereof, process for their preparation and use thereof
12/30/2008CA2368767C Protease resistant flint analogs
12/30/2008CA2353048C Pharmaceutical composition useful in the prevention or treatment of peptic ulcers
12/30/2008CA2351703C Novel 4-dedimethylaminotetracycline derivatives
12/30/2008CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
12/30/2008CA2305139C Disinfectant and method of making
12/30/2008CA2298059C Nucleotide analog composition and synthesis method
12/30/2008CA2245545C Vaccines against varicella zoster virus gene 63 product
12/30/2008CA2215190C Aryl-ester phosphoramidate derivatives of nucleosides
12/30/2008CA2212207C Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
12/30/2008CA2197683C Method for preparing an influenza virus, antigens obtained and applications thereof
12/30/2008CA2132349C Chimeric receptor genes and cells transformed therewith
12/30/2008CA2113744C Methods for regulating the immune response using ctla4-binding molecules and il4-binding molecules
12/25/2008US20080319165 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least one neuropeptide
12/25/2008US20080319064 Deuterium-enriched oseltamivir
12/25/2008US20080319036 administering to overweight subject a pharmaceutical composition comprising a sustained release formulation of zonisamide or a pharmaceutically acceptable salt thereof, either alone or in combination with bupropion or other compound that enhances the activity of norepinephrine and/or dopamine via uptake
12/25/2008US20080319034 Method for producing precious material for ornamental articles and precious material for ornamental articles which can be obtained in particular by means of this method
12/25/2008US20080318998 Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines
12/25/2008US20080318986 Ddc Compositions
12/25/2008US20080318970 Treatment of Infectious Diseases
12/25/2008US20080318959 using 3-amino-5-ethyl-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide
12/25/2008US20080318957 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
12/25/2008US20080318921 5R,6Z)-6-(Imidazo[2,1-b][1,3]benzothiazol-2-ylmethylene)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; beta -Lactamases hydrolyze beta -lactam antibiotics and as such serve as the primary cause of bacterial resistance
12/25/2008US20080318919 Cefquinome Compositions and Methods of Their Use
12/25/2008US20080318918 Methods for Treatment and Prevention of Otitis Media Using Nonionic Surfactants to Facilitate Transmembrane Drug Delivery into the Middle Ear
12/25/2008US20080318916 Novel alpha glucosidase inhibitors from lichens
12/25/2008US20080318906 Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
12/25/2008US20080318904 Deuterium-enriched tenofovir
12/25/2008US20080318894 Rna antagonist compounds for the modulation of her3
12/25/2008US20080318876 Use of Ginsenosides in the Treatment of Aids
12/25/2008US20080318842 Cyclic Isodityrosine Derivatives
12/25/2008US20080318338 Drug screening using a high affinity form of Heat Shock Protein-90 (HSP90) that has a 17-allylamino-geldanamycin (17-AAG) binding affinity
12/25/2008US20080318275 Hepatitis C virus asialoglycoproteins
12/25/2008US20080318227 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
12/25/2008US20080317884 Enhancing Disease Resistance In An Animal
12/25/2008US20080317875 Inhibitor of PI3 kinase-dependent inflammatory cytokine synthesis and method for inhibiting the same
12/25/2008US20080317839 Amino acid lipids and uses thereof
12/25/2008US20080317838 Liposomal Vaccine Compositions Comprising a Polysaccharide Antigen and a Protein Adjuvant
12/25/2008US20080317811 Treatment of Cancer Using Tlr3 Agonists
12/25/2008US20080317799 Nanoemulsion therapeutic compositions and methods of using the same
12/25/2008US20080317785 Vaccine
12/25/2008US20080317784 Immunogenic Compositions Containing Anthrax Antigen, Biodegradable Polymer Microparticles, And Polynucleotide-Containing Immunological Adjuvant
12/25/2008US20080317780 Viral vaccine and method for preparation thereof
12/25/2008US20080317777 Cdna Construct Of Salmonidae Alphavirus
12/25/2008US20080317776 Vaccines Containing Viruses Involved in Avian Malabsorption Syndrome and Methods of Administration Therefor
12/25/2008US20080317772 Compounds and methods for treatment and diagnosis of chlamydial infection
12/25/2008US20080317767 Tripartitle Raftophilic Strutures and their Use
12/25/2008US20080317765 Method for Removal of Toxins from Mucosal Membranes
12/25/2008US20080317762 Bacterial Contact Inhibition and Methods Therefor
12/25/2008US20080317754 Human Osteoclast Derived Cathepsin
12/25/2008US20080317735 Pharmaceutical preparation with RNA as hemostasis cofactor
12/25/2008US20080317724 Micropatterned T cell stimulation
12/25/2008US20080317717 Anti-hepatitis b virus ribozymal nucleic acid
12/25/2008US20080317716 Antigen, nucleic acid that encodes fusion protein; therapy, prevention of tuberculosis infections
12/25/2008US20080317715 Anti-bacterial agents
12/25/2008US20080317714 Method of Treating Hepatitis B Viral Infection
12/25/2008US20080317712 Arylpiperidinyl and arylpyrrolidinyl tripeptide hepatitis c serine protease inhibitors
12/25/2008US20080317690 Dermatological or oral disease; drug delivery; sustained release; onychomycosis; contains benzoin, a topical active agent and a volatile solvent like ethanol
12/24/2008WO2008156853A2 Inhibition of filovirus entry into cells and uses thereof
1 ... 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 ... 1798